To study the efficacy of Dhatryadi kwath and Vasadi kwath in management of Vatarakta (Gout).

Randomised controlled clinical trial to compare the efficacy of dhatryadi kwath and vasadi kwath in management of vatarakta. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056963

Enrollment

150

Registered

2023-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M1A9- Chronic gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran. Patient of any sex, religion and socio-economic status. 2.newly diagnosed patient. 3.Patient with serum uric acid >7mg/dl in male and 6mg/dl in female.

Exclusion criteria

Exclusion criteria: 1.Pathophysiology or genetic syndrome associated with vatarakta. 2.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded. 3 malignancy, poorly controlled DM,HTN. 4.symptomatic patient with clinical evidence of heart failure. 5.complicated patient having target organ damage. 6.alcoholic and drug abusers, pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Reduction in the classical sign and symptoms of vatarakta.Timepoint: 30th, 60th, 90th day	—

Secondary

Measure	Time frame
1.To assess efficacy of Dhatryadi kwath & Vasadi kwath in management of Vatarakta. 2.To assess any adverse effects of Dhatryadi kwath & Vasadi kwath in management of Vatarakta. 3.Decrease in serum uric acid level.Timepoint: 30th, 60th,, 90th day	—

Countries

India

Contacts

Public ContactVd.Ravindra Namdev Sagbhor

Rashtriya Shikshan Mandal,Tilak Ayurved Mahavidyalaya, Rasta Peth, Pune.

drsvdeshpande61@gmail.com09960071113

Outcome results